Clinical Trial Update: A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated MIP-1404 in men with high-risk prostate cancer scheduled for radical prostatectomy and extended pelvic lymph node dissection. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• MIP-1404

Snippet

Sponsor: Molecular Insight Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-30